Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome

BACKGROUND: To evaluate the long-term outcome of bevacizumab therapy for neovascular age related macular degeneration (NVAMD) in the setting of a clinic. METHODS: Consecutive group of NVAMD patients who were treated in a single 3(rd) referral center with bevacizumab using a loading dosage of 3 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Beykin, Gala, Grunin, Michelle, Averbukh, Edward, Banin, Eyal, Hemo, Yitzchak, Chowers, Itay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404564/
https://www.ncbi.nlm.nih.gov/pubmed/25881145
http://dx.doi.org/10.1186/s12886-015-0019-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404564/
https://www.ncbi.nlm.nih.gov/pubmed/25881145
http://dx.doi.org/10.1186/s12886-015-0019-x

Ejemplares similares